Other Species / Isoforms
  PSMA5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S6-p
__MFLTRsEyDrGVN
0 3
PSMA5 (human) __MFLTRsEyDrGVN S6-p
PSMA5 (mouse) __MFLTRSEYDRGVN S6
PSMA5 (rat) __MFLTRSEYDRGVN S6
Y8-p
MFLTRsEyDrGVNtF
0 54
PSMA5 (human) MFLTRsEyDrGVNtF Y8-p
PSMA5 (mouse) MFLTRSEYDRGVNTF Y8
PSMA5 (rat) MFLTRSEYDRGVNTF Y8
R10-m1
LTRsEyDrGVNtFsP
0 1
PSMA5 (human) LTRsEyDrGVNtFsP R10-m1
PSMA5 (mouse) LTRSEYDRGVNTFsP R10
PSMA5 (rat) LTRSEYDRGVNTFsP R10
T14-p
EyDrGVNtFsPEGrL
0 1
PSMA5 (human) EyDrGVNtFsPEGrL T14-p
PSMA5 (mouse) EYDRGVNTFsPEGRL T14
PSMA5 (rat) EYDRGVNTFsPEGRL T14
S16-p
DrGVNtFsPEGrLFQ
Upstream
Downstream
1 45
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, induced
  • signaling pathway regulation
Putative in vivo kinases:
  • CDK1 (human)
Treatment
  • BI_4834
  • cold_shock
  • dinaciclib
  • ischemia
  • MG132_withdrawal
  • nocodazole
  • RO-3306
view more >
PSMA5 (human) DrGVNtFsPEGrLFQ S16-p
PSMA5 (mouse) DRGVNTFsPEGRLFQ S16-p
PSMA5 (rat) DRGVNTFsPEGRLFQ S16-p
R20-m1
NtFsPEGrLFQVEyA
0 1
PSMA5 (human) NtFsPEGrLFQVEyA R20-m1
PSMA5 (mouse) NTFsPEGRLFQVEyA R20
PSMA5 (rat) NTFsPEGRLFQVEYA R20
Y26-p
GrLFQVEyAIEAIKL
0 41
PSMA5 (human) GrLFQVEyAIEAIKL Y26-p
PSMA5 (mouse) GRLFQVEyAIEAIKL Y26-p
PSMA5 (rat) GRLFQVEYAIEGHKL Y26
T36-p
EAIKLGStAIGIQTs
0 1
PSMA5 (human) EAIKLGStAIGIQTs T36-p
PSMA5 (mouse) EAIKLGSTAIGIQTS T36
PSMA5 (rat) EGHKLGSTAIGIQTS T36
S43-p
tAIGIQTsEGVCLAV
0 1
PSMA5 (human) tAIGIQTsEGVCLAV S43-p
PSMA5 (mouse) TAIGIQTSEGVCLAV S43
PSMA5 (rat) TAIGIQTSEGVCLAV S43
K52-ub
GVCLAVEkRItsPLM
0 1
PSMA5 (human) GVCLAVEkRItsPLM K52-ub
PSMA5 (mouse) GVCLAVEKRItsPLM K52
PSMA5 (rat) GVCLAVEKRITsPLM K52
T55-p
LAVEkRItsPLMEPs
0 11
PSMA5 (human) LAVEkRItsPLMEPs T55-p
PSMA5 (mouse) LAVEKRItsPLMEPS T55-p
PSMA5 (rat) LAVEKRITsPLMEPS T55
S56-p
AVEkRItsPLMEPss
Upstream
0 49
Treatment
  • antibody
  • ischemia
PSMA5 (human) AVEkRItsPLMEPss S56-p
PSMA5 (mouse) AVEKRItsPLMEPSS S56-p
PSMA5 (rat) AVEKRITsPLMEPSS S56-p
S62-p
tsPLMEPssIEkIVE
0 1
PSMA5 (human) tsPLMEPssIEkIVE S62-p
PSMA5 (mouse) tsPLMEPSSIEKIVE S62
PSMA5 (rat) TsPLMEPSSIEKIVE S62
S63-p
sPLMEPssIEkIVEI
0 4
PSMA5 (human) sPLMEPssIEkIVEI S63-p
PSMA5 (mouse) sPLMEPSSIEKIVEI S63
PSMA5 (rat) sPLMEPSSIEKIVEI S63
K66-ub
MEPssIEkIVEIDAH
0 1
PSMA5 (human) MEPssIEkIVEIDAH K66-ub
PSMA5 (mouse) MEPSSIEKIVEIDAH K66
PSMA5 (rat) MEPSSIEKIVEIDAH K66
S79-p
AHIGCAMsGLIADAk
0 2
PSMA5 (human) AHIGCAMsGLIADAk S79-p
PSMA5 (mouse) AHIGCAMsGLIADAK S79-p
PSMA5 (rat) AHIGCAMSGLIADAK S79
K86-ub
sGLIADAkTLIDkAR
0 10
PSMA5 (human) sGLIADAkTLIDkAR K86-ub
PSMA5 (mouse) sGLIADAKTLIDKAR K86
PSMA5 (rat) SGLIADAKTLIDkAR K86
K91-ub
DAkTLIDkARVETQN
0 11
PSMA5 (human) DAkTLIDkARVETQN K91-ub
PSMA5 (mouse) DAKTLIDKARVETQN K91
PSMA5 (rat) DAKTLIDKARVETQN K91
K91-ac
DAkTLIDkARVETQN
0 3
PSMA5 (human) DAkTLIDkARVETQN K91-ac
PSMA5 (mouse) DAKTLIDKARVETQN K91
PSMA5 (rat) DAKTLIDkARVETQN K91-ac
K149-ub
LFGGVDEkGPQLFHM
0 1
PSMA5 (human) LFGGVDEkGPQLFHM K149-ub
PSMA5 (mouse) LFGGVDEKGPQLFHM K149
PSMA5 (rat) LFGGVDEKGPQLFHM K149
K149-sm
LFGGVDEkGPQLFHM
0 1
PSMA5 (human) LFGGVDEkGPQLFHM K149-sm
PSMA5 (mouse) LFGGVDEKGPQLFHM K149
PSMA5 (rat) LFGGVDEKGPQLFHM K149
S172-p
CDARAIGsAsEGAQS
0 2
PSMA5 (human) CDARAIGsAsEGAQS S172-p
PSMA5 (mouse) CDARAIGSASEGAQS S172
PSMA5 (rat) CDARAIGSASEGAQS S172
S174-p
ARAIGsAsEGAQSSL
0 1
PSMA5 (human) ARAIGsAsEGAQSSL S174-p
PSMA5 (mouse) ARAIGSASEGAQSSL S174
PSMA5 (rat) ARAIGSASEGAQSSL S174
Y185-p
QSSLQEVyHkSMTLk
0 2
PSMA5 (human) QSSLQEVyHkSMTLk Y185-p
PSMA5 (mouse) QSSLQEVYHkSMTLk Y185
PSMA5 (rat) QSSLQEVYHKSTTLK Y185
K187-ub
SLQEVyHkSMTLkEA
0 12
PSMA5 (human) SLQEVyHkSMTLkEA K187-ub
PSMA5 (mouse) SLQEVYHkSMTLkEA K187-ub
PSMA5 (rat) SLQEVYHKSTTLKEA K187
K192-ub
yHkSMTLkEAIkSSL
Upstream
0 41
Treatment
  • vorinostat
PSMA5 (human) yHkSMTLkEAIkSSL K192-ub
PSMA5 (mouse) YHkSMTLkEAIkssL K192-ub
PSMA5 (rat) YHKSTTLKEAIKSSL K192
K192-sc
yHkSMTLkEAIkSSL
0 1
PSMA5 (human) yHkSMTLkEAIkSSL K192-sc
PSMA5 (mouse) YHkSMTLkEAIkssL K192-sc
PSMA5 (rat) YHKSTTLKEAIKSSL K192
K192-sm
yHkSMTLkEAIkSSL
0 1
PSMA5 (human) yHkSMTLkEAIkSSL K192-sm
PSMA5 (mouse) YHkSMTLKEAIkssL K192
PSMA5 (rat) YHKSTTLKEAIKSSL K192
K196-ub
MTLkEAIkSSLIILk
0 9
PSMA5 (human) MTLkEAIkSSLIILk K196-ub
PSMA5 (mouse) MTLkEAIkssLIILk K196-ub
PSMA5 (rat) TTLKEAIKSSLIILK K196
K196-sm
MTLkEAIkSSLIILk
0 1
PSMA5 (human) MTLkEAIkSSLIILk K196-sm
PSMA5 (mouse) MTLkEAIKssLIILk K196
PSMA5 (rat) TTLKEAIKSSLIILK K196
S197
TLkEAIkSSLIILkQ
0 1
PSMA5 (human) TLkEAIkSSLIILkQ S197
PSMA5 (mouse) TLkEAIkssLIILkQ S197-p
PSMA5 (rat) TLKEAIKSSLIILKQ S197
S198
LkEAIkSSLIILkQV
0 1
PSMA5 (human) LkEAIkSSLIILkQV S198
PSMA5 (mouse) LkEAIkssLIILkQV S198-p
PSMA5 (rat) LKEAIKSSLIILKQV S198
S198
LkEAIkSSLIILkQV
0 1
PSMA5 (human) LkEAIkSSLIILkQV S198
PSMA5 (mouse) LkEAIkssLIILkQV S198-gl
PSMA5 (rat) LKEAIKSSLIILKQV S198
K203-ub
kSSLIILkQVMEEkL
0 11
PSMA5 (human) kSSLIILkQVMEEkL K203-ub
PSMA5 (mouse) kssLIILKQVMEEKL K203
PSMA5 (rat) KSSLIILKQVMEEKL K203
K203
kSSLIILKQVMEEkL
0 1
PSMA5 (human) kSSLIILKQVMEEkL K203
PSMA5 (mouse) kssLIILkQVMEEKL K203-ac
PSMA5 (rat) KSSLIILKQVMEEKL K203
K203-sm
kSSLIILkQVMEEkL
0 1
PSMA5 (human) kSSLIILkQVMEEkL K203-sm
PSMA5 (mouse) kssLIILKQVMEEKL K203
PSMA5 (rat) KSSLIILKQVMEEKL K203
K209-ub
LkQVMEEkLNATNIE
0 9
PSMA5 (human) LkQVMEEkLNATNIE K209-ub
PSMA5 (mouse) LkQVMEEKLNATNIE K209
PSMA5 (rat) LKQVMEEKLNATNIE K209
K209-ac
LkQVMEEkLNATNIE
0 1
PSMA5 (human) LkQVMEEkLNATNIE K209-ac
PSMA5 (mouse) LkQVMEEKLNATNIE K209
PSMA5 (rat) LKQVMEEKLNATNIE K209
K231-ub
QNFHMFTkEELEEVI
0 6
PSMA5 (human) QNFHMFTkEELEEVI K231-ub
PSMA5 (mouse) QNFHMFTKEELEEVI K231
PSMA5 (rat) QNFHMFTKEELEEVI K231
K231-sm
QNFHMFTkEELEEVI
0 1
PSMA5 (human) QNFHMFTkEELEEVI K231-sm
PSMA5 (mouse) QNFHMFTKEELEEVI K231
PSMA5 (rat) QNFHMFTKEELEEVI K231
K239-ub
EELEEVIkDI_____
0 8
PSMA5 (human) EELEEVIkDI_____ K239-ub
PSMA5 (mouse) EELEEVIKDI_____ K239
PSMA5 (rat) EELEEVIKDI_____ K239
K239
EELEEVIKDI_____
0 2
PSMA5 (human) EELEEVIKDI_____ K239
PSMA5 (mouse) EELEEVIkDI_____ K239-ac
PSMA5 (rat) EELEEVIKDI_____ K239
K239-sc
EELEEVIkDI_____
0 1
PSMA5 (human) EELEEVIkDI_____ K239-sc
PSMA5 (mouse) EELEEVIKDI_____ K239
PSMA5 (rat) EELEEVIKDI_____ K239